Near-infrared Spectroscopy Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
1 other identifier
interventional
104
1 country
1
Brief Summary
The aim of this study is to investigate whether near-infrared guided percutaneous coronary intervention in patients with acute myocardial infarction provides improved stent strut coverage at six months compared to conventionally angiography guided percutaneous coronary intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 2, 2020
CompletedFirst Posted
Study publicly available on registry
July 7, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 2, 2023
CompletedJune 11, 2025
June 1, 2025
2 years
July 2, 2020
June 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of stent strut coverage
Proportion of stent strut coverage at 6 months follow up estimated by OCT
6 months after index percutaneous coronary intervention
Secondary Outcomes (3)
Uncovered stent struts
6 months after index percutaneous coronary intervention
Persistent stent malapposition
6 months after index percutaneous coronary intervention
Maximal neointimal growth
6 months after index percutaneous coronary intervention
Study Arms (2)
NIRS-guided PCI
ACTIVE COMPARATORNear-infrared Spectroscopy guided Percutaneous coronary intervention with implantation of drug-eluting stent
Angiography-guided PCI
ACTIVE COMPARATORAngiography-guided percutaneous coronary intervention with implantation of a drug-eluting stent
Interventions
Eligibility Criteria
You may qualify if:
- Patients with acute coronary syndrome (ST-elevation myocardial infarction and non-ST elevation myocardial infarction) referred for invasive coronary angiography and percutaneous coronary intervention at Department of Cardiology, Odense University Hospital (Odense, Denmark)
You may not qualify if:
- participation in other randomized clinical trials
- life expectancy \< 1 year
- allergy to aspirin, clopidogrel, ticagrelor or prasugrel
- eGFR \< 30 mL/min
- tortuous and angiographically estimated extremely calcified lesions
- ostial, left main and bifurcation lesions
- lesions in a reference vessel diameter \< 2.0 mm
- hemodynamic instability
- Scheduled for coronary artery bypass grafting
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Manijeh Noori
Odense, 5000, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Lisette Okkels Jensen, MD PhD Prof
Odense University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Offline data analyzis are being performed without knowing which intervention group the patients are from
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD; PhD-student
Study Record Dates
First Submitted
July 2, 2020
First Posted
July 7, 2020
Study Start
September 1, 2020
Primary Completion
September 1, 2022
Study Completion
March 2, 2023
Last Updated
June 11, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share